The pursuit of market outperformance leads investors to the practice of hand-picking stocks. Skillful choices can be a catalyst for significant wealth enhancement.
The closing price of Atricure Inc (NASDAQ: ATRC) was $35.1 for the day, down -0.09% from the previous closing price of $35.13. In other words, the price has decreased by -$0.09 from its previous closing price. On the day, 0.88 million shares were traded. ATRC stock price reached its highest trading level at $35.78 during the session, while it also had its lowest trading level at $34.18.
Ratios:
Our analysis of ATRC’s different ratios will help us gain a deeper understanding of the company. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 14.75 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 71.74. For the most recent quarter (mrq), Quick Ratio is recorded 2.83 and its Current Ratio is at 3.94. In the meantime, Its Debt-to-Equity ratio is 0.17 whereas as Long-Term Debt/Eq ratio is at 0.16.
On April 23, 2024, Oppenheimer Upgraded its rating to Outperform which previously was Perform but kept the price unchanged to $32.
On October 23, 2023, JMP Securities started tracking the stock assigning a Mkt Outperform rating and target price of $60.JMP Securities initiated its Mkt Outperform rating on October 23, 2023, with a $60 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on May 28 ’25 when Doraiswamy Vinayak sold 2,500 shares for $33.44 per share. The transaction valued at 83,600 led to the insider holds 73,550 shares of the business.
VINAYAK DORAISWAMY bought 2,500 shares of ATRC for $83,600 on May 28 ’25. On Mar 05 ’25, another insider, Prange Karen, who serves as the Director of the company, sold 6,100 shares for $38.12 each. As a result, the insider received 232,532 and left with 17,828 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATRC now has a Market Capitalization of 1744519040 and an Enterprise Value of 1634462080. For the stock, the TTM Price-to-Sale (P/S) ratio is 3.48 while its Price-to-Book (P/B) ratio in mrq is 3.75. Its current Enterprise Value per Revenue stands at 3.269 whereas that against EBITDA is -115.493.
Stock Price History:
The Beta on a monthly basis for ATRC is 1.62, which has changed by 0.5918367 over the last 52 weeks, in comparison to a change of 0.18569505 over the same period for the S&P500. Over the past 52 weeks, ATRC has reached a high of $43.11, while it has fallen to a 52-week low of $20.20. The 50-Day Moving Average of the stock is 8.30%, while the 200-Day Moving Average is calculated to be 3.66%.
Shares Statistics:
ATRC traded an average of 559.39K shares per day over the past three months and 865490 shares per day over the past ten days. A total of 49.69M shares are outstanding, with a floating share count of 47.70M. Insiders hold about 3.64% of the company’s shares, while institutions hold 102.07% stake in the company. Shares short for ATRC as of 1752537600 were 1515237 with a Short Ratio of 2.71, compared to 1749772800 on 1559980. Therefore, it implies a Short% of Shares Outstanding of 1515237 and a Short% of Float of 3.17.
Earnings Estimates
The market rating for Atricure Inc (ATRC) is a result of the insights provided by 8.0 analysts actively involved in the assessment.The consensus estimate for the next quarter is -$0.05, with high estimates of $0.0 and low estimates of -$0.08.
Analysts are recommending an EPS of between -$0.32 and -$0.4 for the fiscal current year, implying an average EPS of -$0.36. EPS for the following year is -$0.21, with 8.0 analysts recommending between -$0.11 and -$0.28.
Revenue Estimates
It is expected that $90B in revenue will be generated in the current quarter, according to 9 analysts. It ranges from a high estimate of $133M to a low estimate of $130.18M. As of the current estimate, Atricure Inc’s year-ago sales were $115.91MFor the next quarter, 9 analysts are estimating revenue of $139.62M. There is a high estimate of $141.39M for the next quarter, whereas the lowest estimate is $138M.
A total of 9 analysts have provided revenue estimates for ATRC’s current fiscal year. The highest revenue estimate was $531.96M, while the lowest revenue estimate was $530M, resulting in an average revenue estimate of $530.61M. In the same quarter a year ago, actual revenue was $465.31MBased on 9 analysts’ estimates, the company’s revenue will be $596.25M in the next fiscal year. The high estimate is $607.18M and the low estimate is $585.8M.
